Gufic Biosciences Limited has informed the Exchange regarding a press release dated May 30, 2023, titled "Press Release Gufic receives DCGI nod for Dalbavancin API and formulation".
Gufic Biosciences Limited has informed the Exchange regarding a press release dated May 30, 2023, titled "Press Release Gufic receives DCGI nod for Dalbavancin API and formulation".